IV Vitamin C
Intravenous high-dose vitamin C was pioneered by Dr. Linus Pauling MD and Dr. Abram Hoffer MD, who treated over 1000 patents with advanced cancer. Over the last 15 years, mounting evidence for the use of intravenous vitamin C in patients with cancer has been published in various peer-reviewed journals. Several different mechanisms of action have been discovered including one that shows vitamin C kills cancer cells by being converted to free radicals inside malignant cells and in turn acts as a selective chemotherapeutic agent. Intravenous vitamin C therapy has been shown to have clinical plausibility and has shown to be well tolerated in the treatment of cancer.
Mounting evidence and well-documented cases of patients with advanced cancers receiving intravenous high-dose vitamin C suggest the use of this therapy as a excellent option to consider in the treatment of cancer.